cancer sequencing
Foundation Medicine, Natera Launch ctDNA Therapy Response Assay With Medicare Coverage
The tissue-informed ctDNA assay is available to US physicians and is eligible for coverage through both the MolDx and New York's CLEP programs.
Realm IDx Cancer Genome Profiling Test Gets National Health Coverage in Japan
The company said it will launch the test, which combines DNA and RNA analysis, for research use only in markets outside of Japan.
Illumina, Pillar Biosciences Ink Global Distribution Agreement for Cancer Dx Assays
The firms said their distribution deal will facilitate the integration of Pillar's precision oncology assays and Illumina's sequencers.
Japanese Lung Cancer Genomic Screening Project Expands in Asia-Pacific
LC-SCRUM-Asia, a genomic screening project and database that initially launched in Japan in 2013, is expanding and will cover additional countries in the Asia-Pacific region.
Studies Assess Tumor Aneuploidy to Guide Immunotherapy Treatment
Results from two new studies suggest that tumor aneuploidy can provide an additional layer of information to help predict response to checkpoint blockade immunotherapy.